drugset / Trial / NCT00942968
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the long term tolerability and safety of dalteparin in subjects with cancer.
Timeline
- Start
- 2009-06
- Primary completion
- 2012-03
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalteparin sodium | Other / unclassified | 200 iu/kg | Subcutaneous |